Здоровье
Исследование показало, что белки могут предсказать, кто заболеет деменцией через 10 лет
A study of frozen blood samples has revealed a trove of proteins that can predict some forms of dementia more than 10 years before the
Чиновники FDA США не выражают новых опасений по поводу сердечного устройства Эбботта
Experts at the US Food and Drug Administration have raised no new concerns about the safety and effectiveness of Abbott’s heart valve repair device for
Генеральный директор Bayer заявил, что компания поддерживает глифосат
Bayer’s CEO said on Friday that the health and crop chemicals group continues to stand firmly behind its glyphosate-based weedkiller even after recently losing a
Акции Moderna и Metagenomi, обеспеченные Bayer, упали на 32%
Shares of Metagenomi Technologies, a genetic drug company backed by Bayer Healthcare, opens a new tab and Moderna, opens a new tab, fell 32% during
Walgreens Boots получила $992 млн после сокращения своей доли в Cencora в третий раз
US pharmacy chain Walgreens Boots Alliance said it had reduced its stake in pharmaceutical distributor Cencora, for the third time in just over six months,
Денге быстро распространяется в Бразилии
Dengue fever has spiked in Brazil during the hot rainy season, prompting health authorities to take emergency measures and start mass vaccination against the mosquito-borne
Высокие дозы спрея, обращающего действие опиоидов, не лучше, чем более низкие дозы в полевых условиях.
A high-dose version of the opioid-reversal spray naloxone, manufactured by Hikma Pharmaceuticals, did not result in increased survival compared with lower-dose versions of the drug
AstraZeneca инвестирует $300 млн в центр клеточной терапии в США
AstraZeneca said on Tuesday it will invest $300 million in a facility in Rockville, Maryland, to discover and develop cell therapies. The U.S. facility will
FDA США обнаружило нарушения контроля на заводе Catalent
In November, US drug regulators found quality control violations at contract drug maker Catalent’s plant in Bloomington, Indiana, including the discovery of “pests” on the
Квартальная выручка Gilead упала на 4%, пероральный препарат от COVID не прошел испытаний
Gilead Sciences said fourth-quarter revenue fell 4 per cent due to lower sales of its HIV drugs and Veklury, a drug contained in them to